Template:Thrombolysis Submassive PE Trials: Difference between revisions
| (One intermediate revision by the same user not shown) | |||
| Line 1: | Line 1: | ||
===[[ | ===[[Thrombolytics for pulmonary embolism]]=== | ||
*Clinical Page | *Clinical Page | ||
**[[Thrombolysis for PE]] | **[[Thrombolysis for PE]] | ||
* | *Research summary page: [[EBQ:Thrombolysis in Pulmonary Embolism Metanalysis]] | ||
**[[EBQ: PEITHO Trial|PEITHO Trial]] | **[[EBQ: PEITHO Trial|PEITHO Trial]] | ||
**[[EBQ: TOPCOAT Trial|TOPCOAT Trial]] | **[[EBQ: TOPCOAT Trial|TOPCOAT Trial]] | ||
**[[EBQ:MOPETT Trial|MOPETT Trial]] | **[[EBQ:MOPETT Trial|MOPETT Trial]] | ||
Latest revision as of 14:24, 11 January 2020
Thrombolytics for pulmonary embolism
- Clinical Page
- Research summary page: EBQ:Thrombolysis in Pulmonary Embolism Metanalysis